Here is What Hedge Funds Think about Gilead Sciences, Inc. (GILD)

Consequently, key money managers were leading the bulls’ herd. Among these funds, Ken Griffin’s Citadel Investment Group initiated a $116.7 million position during the quarter. The following funds were also among the new GILD investors: Hal Mintz’s Sabby Capital, Mike Masters’s Masters Capital Management, and Conan Laughlin’s North Tide Capital.

Let’s now review hedge fund activity in other stocks – not necessarily in the same industry as Gilead Sciences, Inc. (NASDAQ:GILD) but similarly valued. These stocks are BP plc (ADR) (NYSE:BP), Sanofi SA (ADR) (NYSE:SNY), Kraft Heinz Co (NASDAQ:KHC), and NTT Docomo Inc (ADR) (NYSE:DCM). All of these stocks’ market caps are closest to GILD’s market cap.

As you can see these stocks had an average of 30 hedge funds with bullish positions and the average amount invested in these stocks was $8.28 billion. That figure was $3.47 billion in Gilead’s case. Kraft Heinz Co (NASDAQ:KHC) is the most popular stock in this table with 52 funds reporting long positions as of the end of September, while NTT Docomo Inc (ADR) (NYSE:DCM) is the least popular one. Compared to these stocks Gilead Sciences, Inc. (NASDAQ:GILD) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.